Core offer
Tremfya is a prescription medicine for adults with moderately to severely active Crohn's disease and ulcerative colitis, offering self-injection or intravenous infusion.
Tremfya Campaign 1
ChurnedTremfya is a prescription medicine used to treat adults with moderately to severely active Crohn's disease and ulcerative colitis, providing options for self-injection or intravenous infusion.
May 19, 2026
First seen
Jun 9, 2026
Last seen
4
Reads
3
Shows
2
Active months
38s
Avg. length
13-week activity
Public campaign reads by observed week
3
1
Renewal signals
30 dayNo
60 dayNo
90 dayPending
Promo-code persistence
No recurring promo code was observed.
Shows
Where the campaign appeared
Representative reads
Examples across the campaignExample transcript
The read that best represents this campaign's recurring script
The Journal.·Trapped in the Strait of Hormuz
Est. value ~$860range $160–$5.9Klow confidence
[03:09] Speaker 6: For adults with Crohn's disease or ulcerative colitis symptoms, every choice matters. Tremfya offers self injection or intravenous infusion from the start. Tremfya is administered as injections under the skin or infusions through a vein every four weeks, followed by injections under the skin every four or eight weeks. If your doctor decides that you can self inject Tremfya, proper training is required. Tremfya is a prescription medicine used to treat adults with moderately to severely active Crohn's disease and adults with moderately to severely active ulcerative colitis.
More campaigns from Tremfya
Other published campaigns from this sponsor
Tremfya: Prescription medicine for adults with moderately to severely active Crohn's… · Feb 22–Jul 12, 2026Expanding
This campaign promotes Tremfya as a prescription medicine for adults with moderately to severely active Crohn's disease or ulcerative colitis, emphasizing the choice between self-injection or intravenous infusion from the start.
29 reads11 showsLast seen Jul 12
Tremfya: A prescription medicine for adults with moderate to severe plaque psoriasis… · Apr 29–Jun 11, 2026Churned
This campaign promotes Tremfya as a prescription medicine for adults with moderate to severe plaque psoriasis and active psoriatic arthritis, addressing symptoms like joint pain and swelling by offering a path to relief.
6 reads4 showsLast seen Jun 11
Tremfya: Self injection or intravenous infusion from the start · May 14–19, 2026Churned
Tremfya advertising observed across this podcast campaign.
2 reads2 showsLast seen May 19
These signals describe observed podcast advertising activity. Per-read dollar figures are directional current placement proxies—not historical campaign spend, reach, conversions, or return on investment.